Core Viewpoint - The company has been recognized for its innovative practices in the new productive forces and silver economy sectors, showcasing its role in supporting the real economy and technological innovation through insurance capital [1][2]. Group 1: Investment Initiatives - The company has established the first domestic insurance private equity investment fund, the Guoshou Health Fund, with a total scale of 50 billion yuan, focusing on core areas such as biomedicine, artificial intelligence, and semiconductors [2]. - The Guoshou Health Fund has invested in over 60 projects, successfully assisting more than 20 companies to go public, with a total market value of nearly 1 trillion yuan for the listed companies [2]. - The company has launched a silver economy industry investment fund with a total scale of 10 billion yuan, aimed at supporting the national strategy to address population aging [2]. Group 2: Achievements and Recognition - The company and its managed funds have received numerous industry awards, including six consecutive appearances on the China Securities Journal's "Golden Bull List" and nine Golden Bull Awards in total [4]. - The company has been recognized for five consecutive years with the "Insurance Ark Award" by the Securities Times and has been listed among the top 30 venture capital and private equity investment institutions in the medical and health sector by the 21st Century Business Herald for four years [4]. - As of June 2025, the company has accumulated over 200 awards, reflecting its professional strength and market influence [4].

Core Viewpoint - Insurance capital is actively investing in the technology innovation sector through equity funds, exemplified by the establishment of the Shanghai Technology Innovation Phase III Fund, which aims to support strategic emerging industries and high-tech sectors [1][2][5]. Group 1: Fund Establishment and Investment Details - China Pacific Insurance (CPIC) has committed to contribute 800 million yuan to the Shanghai Technology Innovation Phase III Fund, which has a total planned contribution of 8 billion yuan [3][5]. - The fund's total subscription amount is set at 8 billion yuan, with eight companies collectively pledging 3.201 billion yuan so far, all in cash [5]. - The fund focuses on strategic emerging industries such as new-generation information technology, biomedicine, advanced manufacturing, and environmental new energy [5][6]. Group 2: Fund Duration and Profit Distribution - The fund has a lifespan of eight years, consisting of a four-year investment period and a four-year exit period, with the possibility of extension [5]. - Investment returns will be distributed among partners based on their participation ratio in the projects [5]. Group 3: Broader Investment Trends in the Insurance Sector - CPIC has previously participated in the Shanghai Technology Innovation Phase II Fund in 2021, holding a 25% investment share, with a reported investment balance of 1.454 billion yuan by the end of 2024 [8]. - The insurance sector is increasingly exploring equity investments, particularly in areas closely related to its core business, such as health and wellness, as well as in sectors supported by national strategies like new energy and technology manufacturing [9][10]. Group 4: Regulatory Environment and Future Outlook - The Financial Regulatory Authority has expanded the scope of major equity investments by insurance funds to include technology and big data industries, encouraging greater investment in strategic emerging industries [11][12]. - The authority aims to enhance the management of equity investments and ensure that insurance institutions fulfill their responsibilities effectively [13][14].